Achieve Life Sciences (ACHV) Return on Assets (2011 - 2019)
Achieve Life Sciences (ACHV) recorded quarterly Return on Assets of 0.0% in Q3 2019, up 41.05% on a QoQ basis from 0.0% in Q2 2019, and little changed year-over-year from 0.0% in Q3 2018.
Achieve Life Sciences (ACHV) Return on Assets (2011 - 2019) Analysis & Trends
Achieve Life Sciences has disclosed Return on Assets across 8 years of filings, most recently posting 0.0% for Q3 2019.
- Quarterly Return on Assets changed 0.0% year-over-year to 0.0% in Q3 2019, while the trailing twelve-month figure through Sep 2019 was 0.0% (changed 0.0% YoY) and the FY2019 annual result came in at 0.01%, changed 0.0% from the prior year.
- Return on Assets advanced to 0.0% in Q3 2019, from 0.0% in the prior quarter.
- Over five years, Return on Assets peaked at 0.0% in Q4 2015 and troughed at 0.02% in Q1 2018.
- A 5-year average of 0.01% and a median of 0.0% in 2019 frame the typical range for Return on Assets.
- Annual changes were most pronounced in 2018 — Return on Assets fell 2 bps — and 2019, when it gained 1 bps.
- Tracing ACHV's Return on Assets over 5 years: stood at 0.0% in 2015, then sank by 168 bps to 0.0% in 2016, then slumped by 2172 bps to 0.01% in 2017, then soared by 41 bps to 0.01% in 2018, then jumped by 60 bps to 0.0% in 2019.
- Business Quant data shows ACHV's Return on Assets at 0.0% in Q3 2019, 0.0% in Q2 2019, and 0.01% in Q1 2019.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | -0.80% |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | -0.01% |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 0.00% |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | -0.01% |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | 0.00% |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | 0.00% |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 0.00% |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -0.01% |
| 10 | Achieve Life Sciences | 93.71 Mn | 63.22 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | 0.00% |
| Jun 30, 2019 | 0.00% |
| Mar 31, 2019 | -0.01% |
| Dec 31, 2018 | -0.01% |
| Sep 30, 2018 | -0.01% |
| Jun 30, 2018 | -0.01% |
| Mar 31, 2018 | -0.02% |
| Dec 31, 2017 | -0.01% |
| Sep 30, 2017 | -0.01% |
| Jun 30, 2017 | 0.00% |
| Mar 31, 2017 | 0.00% |
| Dec 31, 2016 | 0.00% |
| Sep 30, 2016 | 0.00% |
| Jun 30, 2016 | 0.00% |
| Mar 31, 2016 | 0.00% |
| Dec 31, 2015 | 0.00% |
| Sep 30, 2013 | -0.01% |
| Jun 30, 2013 | 0.00% |
| Mar 31, 2013 | 0.00% |
| Dec 31, 2012 | 0.00% |